Cipla

Cipla completes acquisition of generic businesses in US

Read more

Cipla posts PAT of Rs 343 crore in Q3 FY1516

Read more

Cipla patriarch Y K Hamied increases stake in company to over 20 per cent

Read more

Cipla gets CCI nod to sell stake in consumer healthcare business

Read more

Cipla announces new management council

Read more

Cipla launches anti-ageing skin care product Cutisera

Read more

Cipla ready to launch low-dose Efavirenz 400 mg

Read more

Cipla inks investment pact with FIL Capital Investment

Read more

Delhi HC tells govt not to take coercive steps against pharma cos

Read more

Cipla appoints Naina Lal Kidwai as Independent Director on its Board

Read more